The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib.
Zhuo J, Lu D, Lin Z, Yang X, Yang M, Wang J, Tao Y, Wen X, Li H, Lian Z, Cen B, Dong S, Wei X, Xie H, Zheng S, Shen Y, Xu X.
Zhuo J, et al.
Cell Death Dis. 2021 Nov 16;12(12):1084. doi: 10.1038/s41419-021-04320-4.
Cell Death Dis. 2021.
PMID: 34785656
Free PMC article.